- CA$65.67m
- CA$55.39m
- $2.01m
Annual balance sheet for Realbotix, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.74 | 5.84 | 3.49 | 1.44 | 5.19 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.418 | 0.383 | 0.051 | 0.041 | 0.138 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 40.8 | 6.31 | 3.68 | 1.94 | 5.81 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | — | 0.502 | 0.219 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 43.5 | 20 | 9.87 | 12.2 | 7.09 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.16 | 1.53 | 0.893 | 2.69 | 2.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 21.2 | 5.16 | 0.958 | 4.13 | 3.26 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 22.4 | 14.9 | 8.91 | 8.07 | 3.83 |
| Total Liabilities & Shareholders' Equity | 43.5 | 20 | 9.87 | 12.2 | 7.09 |
| Total Common Shares Outstanding |